Changes of AFP and PIVKA-II levels during DAA treatment and their predictive value for early diagnosis of HCC in HCV cirrhotic patients with SVR to DAA treatment. Issue 1 (February 2018) - Sangiovanni, A.; D'Ambrosio, R.; Lunghi, G.; Bruccoleri, M.; Alimenti, E.; Borghi, M.; Perbellini, R.; Aghemo, A.; Iavarone, M.; Colombo, M.; Lampertico, P.